Tetra Bio-Pharma Signs a Definitive Distribution Agreement with DanCann Pharma to Monetize Its Dronabinol and Botanical Product Portfolios

CANNANNEW REPORT

This Definitive Agreement is expected to generate an excess of $47,5M CAD in revenue for Tetra   OTTAWA, ON / … Read More…..

Excerpt only …
READ MORE BELOW
Source : Tetra Bio-Pharma Signs a Definitive Distribution Agreement with DanCann Pharma to Monetize Its Dronabinol and Botanical Product Portfolios

reposted by Cannabis News World

This site uses Akismet to reduce spam. Learn how your comment data is processed.